 IRVINE, Calif.--BUSINESS WIRE--Axonics Modulation Technologies, Inc. Nasdaq: AXNX, a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation SNM devices for the treatment of urinary and bowel dysfunction, will report fourth quarter and fiscal year 2020 financial results after the market closes on Thursday, February 25, 2021. In conjunction with the release, Axonics will host a conference call at 4:30 p.m. Eastern Time. Interested parti 